Movement Alert｜Sino Biopharmaceutical Falls 3.06% in Regular Trading, Pharmaceutical Sector Under Systematic Selling Pressure Amid High Short-Selling Ratio

Market Focus06-22

On June 22, Sino Biopharmaceutical fell 3.06% in regular trading, trading at 4.39 HKD/share, with turnover of 50.01 million HKD.

On the news front, the pharmaceutical sector continued to face systematic selling pressure, with peers CSPC Pharmaceutical down 4.35%, Hengrui Pharma down 2.84%, United Laboratories down 3.02%, and Fosun Pharma down 2.99%, reflecting broad industry weakness. Morgan Stanley previously cut the company's target price from 8.3 HKD to 7.8 HKD while maintaining an overweight rating. The stock's short-selling ratio remains elevated at 24.21%, indicating strong bearish positioning and significant market divergence. Additionally, leading pharmaceutical companies have recently initiated large-scale share buybacks to support their stock prices, reflecting insufficient confidence in sector valuations overall.

Sino Biopharmaceutical Limited is an investment holding company principally engaged in pharmaceutical business, operating through segments including modern Chinese medicine preparations and western pharmaceuticals, long-term investments, and related medical and hospital services.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180897374?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 09:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180897374","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Sino Biopharmaceutical Falls 3.06% in Regular Trading, Pharmaceutical Sector Under Systematic Selling Pressure Amid High Short-Selling Ratio","media":"Market Focus","content":"<p><p>On June 22, Sino Biopharmaceutical fell 3.06% in regular trading, trading at 4.39 HKD/share, with turnover of 50.01 million HKD.</p><p>On the news front, the pharmaceutical sector continued to face systematic selling pressure, with peers CSPC Pharmaceutical down 4.35%, Hengrui Pharma down 2.84%, United Laboratories down 3.02%, and Fosun Pharma down 2.99%, reflecting broad industry weakness. Morgan Stanley previously cut the company's target price from 8.3 HKD to 7.8 HKD while maintaining an overweight rating. The stock's short-selling ratio remains elevated at 24.21%, indicating strong bearish positioning and significant market divergence. Additionally, leading pharmaceutical companies have recently initiated large-scale share buybacks to support their stock prices, reflecting insufficient confidence in sector valuations overall.</p><p>Sino Biopharmaceutical Limited is an investment holding company principally engaged in pharmaceutical business, operating through segments including modern Chinese medicine preparations and western pharmaceuticals, long-term investments, and related medical and hospital services.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Sino Biopharmaceutical Falls 3.06% in Regular Trading, Pharmaceutical Sector Under Systematic Selling Pressure Amid High Short-Selling Ratio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Sino Biopharmaceutical Falls 3.06% in Regular Trading, Pharmaceutical Sector Under Systematic Selling Pressure Amid High Short-Selling Ratio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-22 09:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 22, Sino Biopharmaceutical fell 3.06% in regular trading, trading at 4.39 HKD/share, with turnover of 50.01 million HKD.</p><p>On the news front, the pharmaceutical sector continued to face systematic selling pressure, with peers CSPC Pharmaceutical down 4.35%, Hengrui Pharma down 2.84%, United Laboratories down 3.02%, and Fosun Pharma down 2.99%, reflecting broad industry weakness. Morgan Stanley previously cut the company's target price from 8.3 HKD to 7.8 HKD while maintaining an overweight rating. The stock's short-selling ratio remains elevated at 24.21%, indicating strong bearish positioning and significant market divergence. Additionally, leading pharmaceutical companies have recently initiated large-scale share buybacks to support their stock prices, reflecting insufficient confidence in sector valuations overall.</p><p>Sino Biopharmaceutical Limited is an investment holding company principally engaged in pharmaceutical business, operating through segments including modern Chinese medicine preparations and western pharmaceuticals, long-term investments, and related medical and hospital services.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1180897374","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180897374","pubTimestamp":1782092820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 22, Sino Biopharmaceutical fell 3.06% in regular trading, trading at 4.39 HKD/share, with turnover of 50.01 million HKD.On the news front, the pharmaceutical sector continued to face...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"异动快讯|中国生物制药常规交易跌3.06%高沽空比率下医药板块遭系统性抛压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"On June 22, Sino Biopharmaceutical fell 3.06% in regular trading, trading at 4.39 HKD/share, with turnover of 50.01 million HKD.On the news front, the pharmaceutical sector continued to face systematic selling pressure, with peers CSPC Pharmaceutical down 4.35%, Hengrui Pharma down 2.84%, United Laboratories down 3.02%, and Fosun Pharma down 2.99%, reflecting broad industry weakness. Morgan Stanley previously cut the company's target price from 8.3 HKD to 7.8 HKD while maintaining an overweight rating. The stock's short-selling ratio remains elevated at 24.21%, indicating strong bearish positioning and significant market divergence. Additionally, leading pharmaceutical companies have recently initiated large-scale share buybacks to support their stock prices, reflecting insufficient confidence in sector valuations overall.Sino Biopharmaceutical Limited is an investment holding company principally engaged in pharmaceutical business, operating through segments including modern Chinese medicine preparations and western pharmaceuticals, long-term investments, and related medical and hospital services.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180897374","isCrawlerRequest":true}